287 related articles for article (PubMed ID: 23254419)
1. Correlation of cell membrane lipid profiles with daptomycin resistance in methicillin-resistant Staphylococcus aureus.
Mishra NN; Bayer AS
Antimicrob Agents Chemother; 2013 Feb; 57(2):1082-5. PubMed ID: 23254419
[TBL] [Abstract][Full Text] [Related]
2. Emergence of daptomycin resistance in daptomycin-naïve rabbits with methicillin-resistant Staphylococcus aureus prosthetic joint infection is associated with resistance to host defense cationic peptides and mprF polymorphisms.
Mishra NN; Yang SJ; Chen L; Muller C; Saleh-Mghir A; Kuhn S; Peschel A; Yeaman MR; Nast CC; Kreiswirth BN; Crémieux AC; Bayer AS
PLoS One; 2013; 8(8):e71151. PubMed ID: 23990934
[TBL] [Abstract][Full Text] [Related]
3. Frequency and Distribution of Single-Nucleotide Polymorphisms within mprF in Methicillin-Resistant Staphylococcus aureus Clinical Isolates and Their Role in Cross-Resistance to Daptomycin and Host Defense Antimicrobial Peptides.
Bayer AS; Mishra NN; Chen L; Kreiswirth BN; Rubio A; Yang SJ
Antimicrob Agents Chemother; 2015 Aug; 59(8):4930-7. PubMed ID: 26055370
[TBL] [Abstract][Full Text] [Related]
4. Association of mprF mutations with cross-resistance to daptomycin and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA).
Thitiananpakorn K; Aiba Y; Tan XE; Watanabe S; Kiga K; Sato'o Y; Boonsiri T; Li FY; Sasahara T; Taki Y; Azam AH; Zhang Y; Cui L
Sci Rep; 2020 Sep; 10(1):16107. PubMed ID: 32999359
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of mprF sequences in methicillin-resistant Staphylococcus aureus clinical isolates: role in cross-resistance between daptomycin and host defense antimicrobial peptides.
Bayer AS; Mishra NN; Sakoulas G; Nonejuie P; Nast CC; Pogliano J; Chen KT; Ellison SN; Yeaman MR; Yang SJ
Antimicrob Agents Chemother; 2014 Dec; 58(12):7462-7. PubMed ID: 25288091
[TBL] [Abstract][Full Text] [Related]
6. Analysis of cell membrane characteristics of in vitro-selected daptomycin-resistant strains of methicillin-resistant Staphylococcus aureus.
Mishra NN; Yang SJ; Sawa A; Rubio A; Nast CC; Yeaman MR; Bayer AS
Antimicrob Agents Chemother; 2009 Jun; 53(6):2312-8. PubMed ID: 19332678
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic and genotypic correlates of daptomycin-resistant methicillin-susceptible Staphylococcus aureus clinical isolates.
Kang KM; Mishra NN; Park KT; Lee GY; Park YH; Bayer AS; Yang SJ
J Microbiol; 2017 Feb; 55(2):153-159. PubMed ID: 28120188
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic and genotypic characterization of daptomycin-resistant methicillin-resistant Staphylococcus aureus strains: relative roles of mprF and dlt operons.
Mishra NN; Bayer AS; Weidenmaier C; Grau T; Wanner S; Stefani S; Cafiso V; Bertuccio T; Yeaman MR; Nast CC; Yang SJ
PLoS One; 2014; 9(9):e107426. PubMed ID: 25226591
[TBL] [Abstract][Full Text] [Related]
9. Causal role of single nucleotide polymorphisms within the mprF gene of Staphylococcus aureus in daptomycin resistance.
Yang SJ; Mishra NN; Rubio A; Bayer AS
Antimicrob Agents Chemother; 2013 Nov; 57(11):5658-64. PubMed ID: 24002096
[TBL] [Abstract][Full Text] [Related]
10. Increased cell wall teichoic acid production and D-alanylation are common phenotypes among daptomycin-resistant methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates.
Bertsche U; Yang SJ; Kuehner D; Wanner S; Mishra NN; Roth T; Nega M; Schneider A; Mayer C; Grau T; Bayer AS; Weidenmaier C
PLoS One; 2013; 8(6):e67398. PubMed ID: 23785522
[TBL] [Abstract][Full Text] [Related]
11. Characterization of compensatory mutations associated with restoration of daptomycin-susceptibility in daptomycin non-susceptible methicillin-resistant Staphylococcus aureus and the role mprF mutations.
Kanesaka I; Fujisaki S; Aiba Y; Watanabe S; Mikawa T; Katsuse AK; Takahashi H; Cui L; Kobayashi I
J Infect Chemother; 2019 Jan; 25(1):1-5. PubMed ID: 30322736
[TBL] [Abstract][Full Text] [Related]
12. VraSR two-component regulatory system contributes to mprF-mediated decreased susceptibility to daptomycin in in vivo-selected clinical strains of methicillin-resistant Staphylococcus aureus.
Mehta S; Cuirolo AX; Plata KB; Riosa S; Silverman JA; Rubio A; Rosato RR; Rosato AE
Antimicrob Agents Chemother; 2012 Jan; 56(1):92-102. PubMed ID: 21986832
[TBL] [Abstract][Full Text] [Related]
13. The Role of
Jiang S; Zhuang H; Zhu F; Wei X; Zhang J; Sun L; Ji S; Wang H; Wu D; Zhao F; Yan R; Yu Y; Chen Y
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0129521. PubMed ID: 34662187
[TBL] [Abstract][Full Text] [Related]
14. LC-MS/MS characterization of phospholipid content in daptomycin-susceptible and -resistant isolates of Staphylococcus aureus with mutations in mprF.
Rubio A; Moore J; Varoglu M; Conrad M; Chu M; Shaw W; Silverman JA
Mol Membr Biol; 2012 Feb; 29(1):1-8. PubMed ID: 22276671
[TBL] [Abstract][Full Text] [Related]
15. Gain-of-Function Mutations in the Phospholipid Flippase MprF Confer Specific Daptomycin Resistance.
Ernst CM; Slavetinsky CJ; Kuhn S; Hauser JN; Nega M; Mishra NN; Gekeler C; Bayer AS; Peschel A
mBio; 2018 Dec; 9(6):. PubMed ID: 30563904
[TBL] [Abstract][Full Text] [Related]
16. VraSR and Virulence Trait Modulation during Daptomycin Resistance in Methicillin-Resistant
Taglialegna A; Varela MC; Rosato RR; Rosato AE
mSphere; 2019 Feb; 4(1):. PubMed ID: 30760612
[TBL] [Abstract][Full Text] [Related]
17. Cell wall thickening is not a universal accompaniment of the daptomycin nonsusceptibility phenotype in Staphylococcus aureus: evidence for multiple resistance mechanisms.
Yang SJ; Nast CC; Mishra NN; Yeaman MR; Fey PD; Bayer AS
Antimicrob Agents Chemother; 2010 Aug; 54(8):3079-85. PubMed ID: 20498310
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of mprF and dltABCD expression among daptomycin-non-susceptible MRSA clinical isolates.
Bayer AS; Mishra NN; Cheung AL; Rubio A; Yang SJ
J Antimicrob Chemother; 2016 Aug; 71(8):2100-4. PubMed ID: 27121398
[TBL] [Abstract][Full Text] [Related]
19. Characterization of genetic changes associated with daptomycin nonsusceptibility in Staphylococcus aureus.
Ma Z; Lasek-Nesselquist E; Lu J; Schneider R; Shah R; Oliva G; Pata J; McDonough K; Pai MP; Rose WE; Sakoulas G; Malik M
PLoS One; 2018; 13(6):e0198366. PubMed ID: 29879195
[TBL] [Abstract][Full Text] [Related]
20. In vivo development of daptomycin resistance in vancomycin-susceptible methicillin-resistant Staphylococcus aureus severe infections previously treated with glycopeptides.
Capone A; Cafiso V; Campanile F; Parisi G; Mariani B; Petrosillo N; Stefani S
Eur J Clin Microbiol Infect Dis; 2016 Apr; 35(4):625-31. PubMed ID: 26815434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
